from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0713/-

LFCtreatmentdescriptionclass of inhibitor

0.957

Amikacinug/mL Amikacintranslation

0.040

Cap5-10ug/mL Capreomycintranslation

0.627

Rox10-50 ug/mL Roxithromycintranslation

0.206

SM2-5 ug/mL Streptomycintranslation

1.451

Tet5-10 ug/mL Tetracyclinetranslation

0.712

Rif0.2-5ug/mL Rifampicintranscription

0.890

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.701

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.031

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.556

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.618

Clofazimine10-13 ug/mL Clofaziminerespiration

0.588

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.675

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.196

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.577

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.460

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.315

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.451

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.080

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.140

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.986

KCN5-20 ug/mL Potassium cyaniderespiration

-0.521

NaN30.2-2 mM Sodium aziderespiration

1.223

Nigericin50 uM Nigericinrespiration

-0.109

TRC10-150 ug/mL Triclosanrespiration

-0.804

TRZ10-25 ug/mL Thioridazinerespiration

-1.586

Valinomycin0.5-10 uM Valinomycinrespiration

0.913

ZnSO42 mM ZnSO4respiration

-0.645

menadione6-10 ug/mL Menadionerespiration

0.244

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.600

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.567

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.460

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.063

NRP_1Non-replicating persistence stage 1dosRassociated

-0.263

Amp0.2mg/mL AmpicillincellWall

0.622

Cephalexin20-100 ug/mL CephalexincellWall

0.284

Cerulenin0.32-5 ug/mL CerulenincellWall

0.009

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.239

EMB10-20 ug/mL EthambutolcellWall

0.414

Eta12-40 ug/mL EthionamidecellWall

0.054

INH0.2-0.4 ug/mL IsoniazidcellWall

0.396

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.802

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.601

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.150

BZA0.12 mg/mL BenzamidearomaticAmides

-0.009

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.313

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.282

H2O24 mM hydrogen peroxideDNAdamaging

0.783

Levo10 ug/mL LevofloxacinDNAdamaging

-0.187

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.913

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.063

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.249

UVUV-irradiationDNAdamaging

-0.316

ARP41-4 ug/mL Antitubercular compound ARP4?

0.950

Antimycin12.5-50 ug/mL Antimycin A?

0.844

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.255

PA_110-50 ug/mL Antitubercular compound PA-1?

0.326

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.940

PA8240.2-2 ug/mL PA-824?

-1.543

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.272

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.367

Verapamil50 uM Verapamil?

0.821

mercaptoethanol2 mM 2-Mercaptoethanol?

0.244

methoxatin10-20 ug/mL Methoxatin?